Cronos Group Inc
CRON: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$7.60 | Csb | Yclvsnkzv |
Cronos' Small Size Is a Challenge to Profitability, but Dilution Risk Is Relatively Small
Business Strategy and Outlook
Cronos Group cultivates and sells cannabis predominantly in Canada and hemp-derived CBD in the U.S. but also participates in the global medical cannabis market.